Reshetnyak AV - Search Results

Year	Number of Results
2000	1
2002	1
2003	1
2006	1
2007	2
2009	2
2013	1
2014	1
2015	2
2016	1
2017	1
2018	1
2021	1
2022	1
2023	1
2024	1
2025	0

1

Mechanism for the activation of the anaplastic lymphoma kinase receptor.

Reshetnyak AV, Rossi P, Myasnikov AG, Sowaileh M, Mohanty J, Nourse A, Miller DJ, Lax I, Schlessinger J, Kalodimos CG. Reshetnyak AV, et al. Nature. 2021 Dec;600(7887):153-157. doi: 10.1038/s41586-021-04140-8. Epub 2021 Nov 24. Nature. 2021. PMID: 34819673 Free PMC article.

2

Retrospective comparative analysis of two medical evacuation systems for Ukrainian patients affected by war.

Mueller A, Salek M, Oszer A, Evseev D, Yakimkova T, Wlodarski M, Vinitsky A, Kizyma R, Pogorelyy M, Zuber M, Escalante J, Lipska E, Fendler W, Nowicka Z, Szyszka A, Kacharian A, Rodriguez-Galindo C, Wise PH, Agulnik A, Mlynarski W; SAFER Ukraine collaborative. Mueller A, et al. Eur J Cancer. 2024 Oct;210:114271. doi: 10.1016/j.ejca.2024.114271. Epub 2024 Aug 8. Eur J Cancer. 2024. PMID: 39232428 Free article.

3

Antibody proteases: induction of catalytic response.

Gabibov AG, Friboulet A, Thomas D, Demin AV, Ponomarenko NA, Vorobiev II, Pillet D, Paon M, Alexandrova ES, Telegin GB, Reshetnyak AV, Grigorieva OV, Gnuchev NV, Malishkin KA, Genkin DD. Gabibov AG, et al. Among authors: reshetnyak av. Biochemistry (Mosc). 2002 Oct;67(10):1168-79. doi: 10.1023/a:1020971509138. Biochemistry (Mosc). 2002. PMID: 12460115 Free article.

4

Identification of a biologically active fragment of ALK and LTK-Ligand 2 (augmentor-α).

Reshetnyak AV, Mohanty J, Tomé F, Puleo DE, Plotnikov AN, Ahmed M, Kaur N, Poliakov A, Cinnaiyan AM, Lax I, Schlessinger J. Reshetnyak AV, et al. Proc Natl Acad Sci U S A. 2018 Aug 14;115(33):8340-8345. doi: 10.1073/pnas.1807881115. Epub 2018 Jul 30. Proc Natl Acad Sci U S A. 2018. PMID: 30061385 Free PMC article.

5

Structural basis for KIT receptor tyrosine kinase inhibition by antibodies targeting the D4 membrane-proximal region.

Reshetnyak AV, Nelson B, Shi X, Boggon TJ, Pavlenco A, Mandel-Bausch EM, Tome F, Suzuki Y, Sidhu SS, Lax I, Schlessinger J. Reshetnyak AV, et al. Proc Natl Acad Sci U S A. 2013 Oct 29;110(44):17832-7. doi: 10.1073/pnas.1317118110. Epub 2013 Oct 14. Proc Natl Acad Sci U S A. 2013. PMID: 24127596 Free PMC article.

6

Strategies for induction of catalytic antibodies toward HIV-1 glycoprotein gp120 in autoimmune prone mice.

Durova OM, Vorobiev II, Smirnov IV, Reshetnyak AV, Telegin GB, Shamborant OG, Orlova NA, Genkin DD, Bacon A, Ponomarenko NA, Friboulet A, Gabibov AG. Durova OM, et al. Among authors: reshetnyak av. Mol Immunol. 2009 Nov;47(1):87-95. doi: 10.1016/j.molimm.2008.12.020. Epub 2009 Feb 6. Mol Immunol. 2009. PMID: 19201029

7

The strength and cooperativity of KIT ectodomain contacts determine normal ligand-dependent stimulation or oncogenic activation in cancer.

Reshetnyak AV, Opatowsky Y, Boggon TJ, Folta-Stogniew E, Tome F, Lax I, Schlessinger J. Reshetnyak AV, et al. Mol Cell. 2015 Jan 8;57(1):191-201. doi: 10.1016/j.molcel.2014.11.021. Epub 2014 Dec 24. Mol Cell. 2015. PMID: 25544564 Free PMC article.

8

Induction of a protein-targeted catalytic response in autoimmune prone mice: antibody-mediated cleavage of HIV-1 glycoprotein GP120.

Ponomarenko NA, Vorobiev II, Alexandrova ES, Reshetnyak AV, Telegin GB, Khaidukov SV, Avalle B, Karavanov A, Morse HC 3rd, Thomas D, Friboulet A, Gabibov AG. Ponomarenko NA, et al. Among authors: reshetnyak av. Biochemistry. 2006 Jan 10;45(1):324-30. doi: 10.1021/bi050675k. Biochemistry. 2006. PMID: 16388609

9

Distinct cellular properties of oncogenic KIT receptor tyrosine kinase mutants enable alternative courses of cancer cell inhibition.

Shi X, Sousa LP, Mandel-Bausch EM, Tome F, Reshetnyak AV, Hadari Y, Schlessinger J, Lax I. Shi X, et al. Among authors: reshetnyak av. Proc Natl Acad Sci U S A. 2016 Aug 16;113(33):E4784-93. doi: 10.1073/pnas.1610179113. Epub 2016 Aug 1. Proc Natl Acad Sci U S A. 2016. PMID: 27482095 Free PMC article.

10

Augmentor α and β (FAM150) are ligands of the receptor tyrosine kinases ALK and LTK: Hierarchy and specificity of ligand-receptor interactions.

Reshetnyak AV, Murray PB, Shi X, Mo ES, Mohanty J, Tome F, Bai H, Gunel M, Lax I, Schlessinger J. Reshetnyak AV, et al. Proc Natl Acad Sci U S A. 2015 Dec 29;112(52):15862-7. doi: 10.1073/pnas.1520099112. Epub 2015 Nov 16. Proc Natl Acad Sci U S A. 2015. PMID: 26630010 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Results by year